Anti‐sclerostin antibodies for the treatment of osteoporosis
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the benefits and harms of anti‐sclerostin antibodies for the treatment of osteoporosis.